Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody

© 2023. The Author(s)..

Rodent-borne hantaviruses are prevalent worldwide and upon spillover to human populations, cause severe disease for which no specific treatment is available. A potent antibody response is key for recovery from hantavirus infection. Here we study a highly neutralizing human monoclonal antibody, termed SNV-42, which was derived from a memory B cell isolated from an individual with previous Sin Nombre virus (SNV) infection. Crystallographic analysis demonstrates that SNV-42 targets the Gn subcomponent of the tetrameric (Gn-Gc)4 glycoprotein assembly that is relevant for viral entry. Integration of our 1.8 Å structure with the (Gn-Gc)4 ultrastructure arrangement indicates that SNV-42 targets the membrane-distal region of the virus envelope. Comparison of the SNV-42 paratope encoding variable genes with inferred germline gene segments reveals high sequence conservation, suggesting that germline-encoded antibodies inhibit SNV. Furthermore, mechanistic assays reveal that SNV-42 interferes with both receptor recognition and fusion during host-cell entry. This work provides a molecular-level blueprint for understanding the human neutralizing antibody response to hantavirus infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Nature microbiology - 8(2023), 7 vom: 15. Juli, Seite 1293-1303

Sprache:

Englisch

Beteiligte Personen:

Stass, Robert [VerfasserIn]
Engdahl, Taylor B [VerfasserIn]
Chapman, Nathaniel S [VerfasserIn]
Wolters, Rachael M [VerfasserIn]
Handal, Laura S [VerfasserIn]
Diaz, Summer M [VerfasserIn]
Crowe, James E [VerfasserIn]
Bowden, Thomas A [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Monoclonal
Antibodies, Neutralizing
Glycoproteins
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 07.07.2023

Date Revised 19.07.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41564-023-01413-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358237017